<VariationArchive RecordType="classified" VariationID="31021" VariationName="NM_032444.4(SLX4):c.286del (p.Thr96fs)" VariationType="Deletion" Accession="VCV000031021" Version="6" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-11-11" DateCreated="2013-09-08" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="39978" VariationID="31021">
      <GeneList>
        <Gene Symbol="SLX4" FullName="SLX4 structure-specific endonuclease subunit" GeneID="84464" HGNC_ID="HGNC:23845" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="3581181" stop="3611606" display_start="3581181" display_stop="3611606" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="3631181" stop="3661584" display_start="3631181" display_stop="3661584" Strand="-" />
          </Location>
          <OMIM>613278</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_032444.4(SLX4):c.286del (p.Thr96fs)</Name>
      <CanonicalSPDI>NC_000016.10:3608678:TTT:TT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="3608679" stop="3608679" display_start="3608679" display_stop="3608679" variantLength="1" positionVCF="3608678" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="3658680" stop="3658680" display_start="3658680" display_stop="3658680" variantLength="1" positionVCF="3658679" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>T96fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.3608681del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.3608681del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.3658682del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.3658682del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_028123.1" sequenceAccession="NG_028123" sequenceVersion="1" change="g.7906del">
            <Expression>NG_028123.1:g.7906del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032444.4" sequenceAccession="NM_032444" sequenceVersion="4" change="c.286del" MANESelect="true">
            <Expression>NM_032444.4:c.286del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_115820.2" sequenceAccession="NP_115820" sequenceVersion="2" change="p.Thr96fs">
            <Expression>NP_115820.2:p.Thr96fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_503" sequenceAccession="LRG_503">
            <Expression>LRG_503:g.7906del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_503t1" sequenceAccession="LRG_503t1">
            <Expression>LRG_503t1:c.286del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="613278.0001" DB="OMIM" />
        <XRef Type="rs" ID="1596534281" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_032444.4(SLX4):c.286del (p.Thr96fs) AND Fanconi anemia complementation group P" Accession="RCV000024014" Version="7">
        <ClassifiedConditionList TraitSetID="7506">
          <ClassifiedCondition DB="MedGen" ID="C3469542">Fanconi anemia complementation group P</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-02-10" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-02-10" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-09-08" MostRecentSubmission="2023-11-11">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21240277</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7506" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16049" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Fanconi anemia complementation group P</ElementValue>
                <XRef ID="MONDO:0013499" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FANCP</ElementValue>
                <XRef Type="MIM" ID="613951" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Fanconi anemia (FA) is characterized by physical abnormalities, bone marrow failure, and increased risk for malignancy. Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies. Progressive bone marrow failure with pancytopenia typically presents in the first decade, often initially with thrombocytopenia or leukopenia. The incidence of acute myeloid leukemia is 13% by age 50 years. Solid tumors – particularly of the head and neck, skin, and genitourinary tract – are more common in individuals with FA.</Attribute>
                <XRef ID="NBK1401" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15731" />
                <XRef ID="15731" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301575</ID>
                <ID Source="BookShelf">NBK1401</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="FARF, 2008">
                <URL>http://www.fanconi.org/images/uploads/other/Guidelines_for_Diagnosis_and_Management.pdf</URL>
                <CitationText>Fanconi Anemia Research Fund, Guidelines for Diagnosis and Management, 2008 (See 2020 Update)</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="FARF, 2020">
                <URL>https://www.fanconi.org/images/uploads/other/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.pdf</URL>
                <CitationText>Fanconi Anemia Clinical Care Guidelines, Fifth Edition.</CitationText>
              </Citation>
              <XRef ID="84" DB="Orphanet" />
              <XRef ID="C3469542" DB="MedGen" />
              <XRef ID="MONDO:0013499" DB="MONDO" />
              <XRef Type="MIM" ID="613951" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2692385" SubmissionDate="2020-02-27" DateLastUpdated="2020-06-28" DateCreated="2020-06-28">
        <ClinVarSubmissionID localKey="SLX4_000001|OMIM:613951" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001364635" DateUpdated="2020-06-28" DateCreated="2020-06-28" Type="SCV" Version="1" SubmitterName="Leiden Open Variation Database" OrgID="506264" OrganizationCategory="other" OrgAbbreviation="LOVD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-02-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21240277</ID>
          </Citation>
          <Comment>Curator: Arleen D. Auerbach. Submitter to LOVD: Arleen D. Auerbach.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLX4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_032444.2:c.286delA</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.3658680_3658680del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613951" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7043292</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="50561" SubmissionDate="2019-04-19" DateLastUpdated="2023-11-11" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="613278.0001_FANCONI ANEMIA, COMPLEMENTATION GROUP P" title="SLX4, 1-BP DEL, 286A_FANCONI ANEMIA, COMPLEMENTATION GROUP P" />
        <ClinVarAccession Accession="SCV000045305" DateUpdated="2023-11-11" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Dutch boy, born of consanguineous parents, with Fanconi anemia of complementation group P (FANCP; 613951), Stoepker et al. (2011) identified a homozygous 1-bp deletion (286delA) in exon 1 of the SLX4 gene, resulting in a frameshift and premature termination at codon 126. Patient lymphoblasts showed spontaneous chromosomal breakage as well as chromosomal breakage in response to mitomycin C and camptothecin. Immunoassays of patient lymphoblasts did not detect a full-length protein, but there was a small amount of residual truncated protein identified with antibodies against the C terminus, which may have been derived from an alternative translation initiation site at codon 213 in the SLX4 gene. Transient expression in HEK293 cells of a truncated protein starting at met213 showed that it was able to interact with ERCC1 (126380), MUS81 (606591)-EME1 (610885), and SLX1. The cellular defects in this patient were believed to result from low levels of a truncated protein, resulting in a defect in the interaction of SLX4 with ERCC1. Transfection of a partial mouse Slx4 protein in patient cells partially restored chromosome breakage defects. The patient had growth retardation, mild dysmorphic features, hypoplastic right thumb, and pancytopenia.</Attribute>
              <Citation>
                <ID Source="PubMed">21240277</ID>
              </Citation>
              <XRef DB="OMIM" ID="613951" Type="MIM" />
              <XRef DB="OMIM" ID="126380" Type="MIM" />
              <XRef DB="OMIM" ID="606591" Type="MIM" />
              <XRef DB="OMIM" ID="610885" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLX4" />
          </GeneList>
          <Name>SLX4, 1-BP DEL, 286A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 286A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613278.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FANCONI ANEMIA, COMPLEMENTATION GROUP P</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2692385" TraitType="Disease" MappingType="XRef" MappingValue="613951" MappingRef="OMIM">
        <MedGen CUI="C3469542" Name="Fanconi anemia complementation group P" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="50561" TraitType="Disease" MappingType="Name" MappingValue="FANCONI ANEMIA, COMPLEMENTATION GROUP P" MappingRef="Preferred">
        <MedGen CUI="C3469542" Name="Fanconi anemia complementation group P" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

